Variant report
Variant | nsv981122 |
---|---|
Chromosome Location | chr6:28525054-28526283 |
allele | n/a |
Outlinks | Ensembl   UCSC |
- TF binding region (count:0)
- CpG islands (count:0)
- Chromatin interactive region (count:0)
- LncRNA region (count:0)
- Mature miRNA region (count: 0)
- miRNA target sites (count:0)
No data |
No data |
No data |
No data |
No data |
No data |
No data |

No. | Variant name | Chromosome position | Chromatin state | Related regulatory elements | Target genes | Extended variants | Associated traits |
---|---|---|---|---|---|---|---|
1 | rs566306246 | chr6:28525096-28525097 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
2 | rs537068279 | chr6:28525108-28525109 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
3 | rs376001869 | chr6:28525198-28525199 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
4 | rs566812973 | chr6:28525201-28525202 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
5 | rs550563409 | chr6:28525218-28525219 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
6 | rs140397747 | chr6:28525255-28525256 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
7 | rs536191562 | chr6:28525263-28525264 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
8 | rs9295772 | chr6:28525265-28525266 | Weak transcription | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
9 | rs151191361 | chr6:28525273-28525274 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
10 | rs9295773 | chr6:28525301-28525302 | Weak transcription | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
11 | rs9348806 | chr6:28525379-28525380 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
12 | rs371507423 | chr6:28525442-28525443 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
13 | rs183764558 | chr6:28525448-28525449 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
14 | rs186688476 | chr6:28525527-28525528 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
15 | rs192321865 | chr6:28525540-28525541 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
16 | rs149948622 | chr6:28525542-28525543 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
17 | rs574267681 | chr6:28525546-28525547 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
18 | rs543379227 | chr6:28525547-28525548 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
19 | rs576563618 | chr6:28525570-28525571 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
20 | rs576539023 | chr6:28525598-28525599 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
21 | rs13204325 | chr6:28525621-28525622 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
22 | rs528718472 | chr6:28525623-28525624 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
23 | rs148409951 | chr6:28525662-28525663 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
24 | rs7756053 | chr6:28525669-28525670 | Weak transcription | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
25 | rs190113000 | chr6:28525670-28525671 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
26 | rs530381115 | chr6:28525671-28525672 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
27 | rs550550180 | chr6:28525685-28525686 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
28 | rs572676147 | chr6:28525695-28525696 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
29 | rs567188946 | chr6:28525696-28525697 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
30 | rs142509240 | chr6:28525722-28525723 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
31 | rs552792638 | chr6:28525758-28525759 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
32 | rs112326468 | chr6:28525813-28525814 | Active TSS Weak transcription Bivalent/Poised TSS | n/a | n/a | Overlapped CNVs | n/a |
33 | rs371943544 | chr6:28525830-28525831 | Active TSS Weak transcription Bivalent/Poised TSS | n/a | n/a | Overlapped CNVs | n/a |
34 | rs546515032 | chr6:28525855-28525856 | Active TSS Weak transcription Bivalent/Poised TSS | n/a | n/a | Overlapped CNVs | n/a |
35 | rs566300662 | chr6:28525883-28525884 | Active TSS Weak transcription Bivalent/Poised TSS | n/a | n/a | Overlapped CNVs | n/a |
36 | rs538461613 | chr6:28525887-28525888 | Active TSS Weak transcription Bivalent/Poised TSS | n/a | n/a | Overlapped CNVs | n/a |
37 | rs574606095 | chr6:28525895-28525896 | Active TSS Weak transcription Bivalent/Poised TSS | n/a | n/a | Overlapped CNVs | n/a |
38 | rs9468390 | chr6:28525926-28525927 | Active TSS Weak transcription Bivalent/Poised TSS | n/a | n/a | Overlapped CNVs | n/a |
39 | rs117066948 | chr6:28525996-28525997 | Active TSS Weak transcription Bivalent/Poised TSS | n/a | n/a | Overlapped CNVs | n/a |
40 | rs578050672 | chr6:28526037-28526038 | Active TSS Weak transcription Bivalent/Poised TSS | n/a | n/a | Overlapped CNVs | n/a |
41 | rs181866170 | chr6:28526050-28526051 | Active TSS Weak transcription Bivalent/Poised TSS | n/a | n/a | Overlapped CNVs | n/a |
42 | rs557308890 | chr6:28526111-28526112 | Active TSS Weak transcription Bivalent/Poised TSS | n/a | n/a | Overlapped CNVs | n/a |
43 | rs434636 | chr6:28526156-28526157 | Active TSS Weak transcription Bivalent/Poised TSS | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
44 | rs563616688 | chr6:28526255-28526256 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
45 | rs533478227 | chr6:28526277-28526278 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
Disease | PMID | Source |
---|---|---|
Acute lymphoblastic leukemia | 22237106 | CNVD |
Follicular lymphoma | 20505157 | CNVD |
Glioblastoma multiforme | 21080181 | CNVD |
Ewing''s sarcoma | 21437220 | CNVD |
Basal cell lymphoma | 16317097 | CNVD |
Diffuse large b-cell lymphoma | 16317097 | CNVD |
Leukemia | 21518781 | CNVD |
Cancer | 21637783 | CNVD |
Facial dysmorphism | 22105932 | CNVD |
Medulloblastoma | 21979893 | CNVD |
Non-syndromic sensorineural hearing loss | 18471307 | CNVD |
Diffuse large b-cell lymphoma | 18287131 | CNVD |
Esophageal squamous carcinoma | 21637470 | CNVD |
Glioblastoma multiforme | 19960244 | CNVD |
Hepatocellular carcinoma | 22174799 | CNVD |
Endometrial cancer | 22040021 | CNVD |
Acute myeloid leukemia | 16864856 | CNVD |
Breast cancer | 21264507 | CNVD |
Acute lymphoblastic leukemia | 20067559 | CNVD |
Cancer | 16751803 | CNVD |
Bladder cancer | 19088036 | CNVD |
Wilms tumour | 21544195 | CNVD |
Uveal melanoma | 21693616 | CNVD |
Biliary cancer | 19435499 | CNVD |
Malaria | 21533027 | CNVD |
Retinoblastoma | 19183342 | CNVD |
Acute myeloid leukemia | 20729466 | CNVD |
T-cell prolymphocytic leukemia | 19278963 | CNVD |
Breast cancer | 20668451 | CNVD |
Cancer | 20668451 | CNVD |
Lung cancer | 20668451 | CNVD |
Ovarian cancer | 20668451 | CNVD |
Pancreas cancer | 20668451 | CNVD |
Prostate cancer | 20668451 | CNVD |
Acute lymphoblastic leukemia | 20435627 | CNVD |
Prostate cancer | 18632612 | CNVD |
Breast cancer | 21858162 | CNVD |
Lung cancer | 18438408 | CNVD |
Ewing''s sarcoma | 17952124 | CNVD |
Gastric cancer | 16891809 | CNVD |
Ovarian cancer | 21781307 | CNVD |
Autism | 21448237 | CNVD |
Cancer | 20164919 | CNVD |
Melanoma | 18172304 | CNVD |
Breast cancer | 22844521 | CNVD |
HIV/AIDS | 22844521 | CNVD |
Ovarian cancer | 22844521 | CNVD |
Prostate cancer | 22844521 | CNVD |
Psoriasis | 22844521 | CNVD |
Rheumatoid arthritis | 22844521 | CNVD |
Sclerosis systemic | 22844521 | CNVD |
Systemic lupus erythematosus | 22844521 | CNVD |
Breast cancer | 22522925 | CNVD |
Breast cancer | 21552322 | CNVD |
Immune disease | 21076436 | CNVD |
Autoimmune disease | 19135723 | CNVD |
Systemic lupus erythematosus | 17953491 | CNVD |
Recurrent Infections | 22737222 | CNVD |
Systemic lupus erythematosus | 21904924 | CNVD |
Ependymoma | 19289631 | CNVD |
Gestational infection | 22844521 | CNVD |
Head circumference | 22844521 | CNVD |
Infertility | 22844521 | CNVD |
Recurrent birth weight diabetes | 22844521 | CNVD |
Obesity | 22844521 | CNVD |
Recurrent pregnancy loss | 22844521 | CNVD |
Intellectual disability | 21811512 | CNVD |
Chronic lymphocytic leukemia | 21546498 | CNVD |
Congenital anomalies of the kidney and urinary tract | 18694510 | CNVD |
Nasopharyngeal cancer | 22815911 | CNVD |
Hepatocellular carcinoma | 16750200 | CNVD |
Basal cell lymphoma | 21115979 | CNVD |
Acute lymphoblastic leukemia | 21339820 | CNVD |
Breast cancer | 17133270 | CNVD |
Autism | 22495311 | CNVD |
Cancer | 16790693 | CNVD |
Breast cancer | 22032731 | CNVD |
Cervical cancer | 21062161 | CNVD |
Breast cancer | 21785460 | CNVD |
Retinoblastoma | 16790693 | CNVD |
Esophageal adenocarcinoma | 18820669 | CNVD |
Systemic lupus erythematosus | 17503323 | CNVD |
Endometrioid adenocarcinoma | 16974079 | CNVD |
T-cell lymphomas | 19863542 | CNVD |
Urothelial carcinoma | 18382360 | CNVD |
Cancer | 21183584 | CNVD |
Hodgkin''s lymphoma | 17606441 | CNVD |
small cell lung cancer | 20016488 | CNVD |
Renal cell carcinoma | 18765545 | CNVD |
Oral squamous cell carcinoma | 17134496 | CNVD |
Gastric cancer | 17908304 | CNVD |
Myelofibrosis | 22110671 | CNVD |
Breast cancer | 16397240 | CNVD |
Metanephric adenoma | 20802469 | CNVD |
Splenic marginal zone lymphoma | 21957467 | CNVD |
Breast cancer | 21364760 | CNVD |
Schizophrenia | 19571809 | CNVD |
Schizophrenia | 19571808 | CNVD |
Malignant peripheral nerve sheath tumor | 18522746 | CNVD |
Neuroblastoma | 16790693 | CNVD |
T-cell prolymphocytic leukemia | 17713554 | CNVD |
abnormal development | 18461090 | CNVD |
Non-syndromic sensorineural hearing loss | 18451855 | CNVD |
No. | Chromosome Location | Chromatin state | Cell line | Tissue |
---|---|---|---|---|
1 | chr6:28523200-28530600 | Weak transcription | H1 Derived Neuronal Progenitor Cultured Cells | ES cell derived |
2 | chr6:28523400-28528600 | Weak transcription | K562 | blood |
3 | chr6:28523600-28531400 | Weak transcription | HepG2 | liver |
4 | chr6:28525800-28526200 | Active TSS | ES-I3 Cell Line | embryonic stem cell |
5 | chr6:28525800-28526200 | Bivalent/Poised TSS | iPS-15b Cell Line | embryonic stem cell |